BioMarin to Host Second Quarter 2016 Financial Results Conference Call and Webcast on Thursday, August 4 at 4:30pm ET
July 14 2016 - 8:30AM
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced that
Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of
BioMarin, will host a conference call and webcast on Thursday,
August 4, at 4:30 p.m. ET to discuss second quarter 2016 financial
results and provide a general business update.
Dial-in Number U.S. / Canada Dial-in
Number: (877) 303-6313 International Dial-in Number: (631) 813-4734
Conference ID: 40166552
Replay Dial-in Number: (855) 859-2056 Replay International
Dial-in Number: (404) 537-3406 Conference ID: 40166552
Interested parties may access a live audio
webcast of the conference call via the investor section of the
BioMarin website, www.biomarin.com. A replay of the call will
be archived on the site for one week following the call.
About BioMarin
BioMarin is a global biotechnology company that
develops and commercializes innovative therapies for patients with
serious and life-threatening rare and ultra-rare genetic diseases.
The company's portfolio consists of five commercialized products
and multiple clinical and pre-clinical product candidates. For
additional information, please visit www.biomarin.com.
Contacts:
Investors
Traci McCarty
BioMarin Pharmaceutical Inc.
(415) 455-7558
Media
Debra Charlesworth
BioMarin Pharmaceutical Inc.
(415) 455-7451
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Apr 2023 to Apr 2024